Pilot corpus: NIH-funded biomedical datasets. Any DOI can be scored on demand — network effects sharpen as coverage grows.

Jak1 Inhibition Is Sufficient for Treatment of Granuloma Annulare

Journal of Investigative Dermatology(2025)10.1016/j.jid.2025.04.030Source: DataRank Database

Jak1 Inhibition Is Sufficient for Treatment of Granuloma Annulare is a research paper published in Journal of Investigative Dermatology (2025). On theSindex it has a DataRank of 0. It has been cited 4 times.

N/A

0DataRank · unranked

Scored on demand from live citation data

Open Access4 citations

Download PDF

Cite:

Linked data & code

nct

DataRank reads this dataset's downstream impact straight off the citation graph — no black box, no proprietary weighting. How is this computed?

›Methodology & internals

datarank_citation_only_1hop_v6· scope data_onlyMethodology

Pipeline:MetadataData-paper checkEnrichmentCitation networkScoring

Enrichment:Funding (9 grants)Impact (FWCI 4.25)OA: greenTopics (11)IDs (PubMed, PMC, OpenAlex)Annotations (1)SDGs (1)

FAIR Checklist

Context only (not used in score)

Findable (1/2)

Has DOI

Accessible (1/2)

Open Access

Interoperable (0/2)

Reusable (0/3)

FAIR checklist signals are shown for context only and do not affect DataRank scoring.

Run a calibrated FAIR evaluation for this paper →

We only score data papers we can read in full — never from an abstract alone.

Authors (8)

Erica Hwang ORCID,Okeroghene Rufin,Bridget E. Shields ORCID,Misha Rosenbach,Yiwei Wang ORCID

Live enrichment

PubMed:40383463 PMC:PMC12641425 OpenAlex:https://openalex.org/W4410421893

National Institutes of Health

Grant: 1S10OD030363-01A1

High Performance Computing Instrumentation for the Yale Center for Genome Analysis

NIAID NIH HHS

Grant: K08 AI159229

NIH HHS

Grant: S10 OD030363

NHLBI NIH HHS

Grant: T35 HL007649

Basic Energy Sciences

National Institute of General Medical Sciences

Pfizer Inc

NIAID

Pfizer

FWCI

4.25

Citation Percentile

0.9%

Citation Trend

2025

2026

greenLicense: Elsevier TDM

repositoryhttps://pmc.ncbi.nlm.nih.gov/articles/PMC12641425/

publisherhttps://api.elsevier.com/content/article/PII:S0022202X25004841?httpAccept=text/xml

publisherhttps://api.elsevier.com/content/article/PII:S0022202X25004841?httpAccept=text/plain

journalhttps://doi.org/10.1016/j.jid.2025.04.030

Fields of Study

Skin Diseases and DiabetesPsoriasis: Treatment and PathogenesisInflammatory Myopathies and Dermatomyositis03 medical and health sciences0302 clinical medicine

Keywords

Granuloma annulareDermatologyMedicineJak InhibitorAbrocitinibArticle

Sustainable Development Goals

SDG 0: Zero hunger

Jak1 Inhibition Is Sufficient for Treatment of Granuloma Annulare

FAIR Checklist

Authors (8)

Funding (9 grants)

Impact

Open Access

Topics

Annotations (Europe PMC)